Skip to main content

Animations

MJFF Publications

1941 - 1950 of 8715 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gap
    Journal Name: The Lancet Digital Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/s2589-7500(22)00190-x
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Inconsistency and incongruence: the two diagnostic pillars of functional movement disorder
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s0140-6736(22)01184-9
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Movement disorders research in 2021: cracking the paradigm
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Revisiting levodopa for advanced Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Major advances in Parkinson's disease over the past two decades and future research directions
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study
    Journal Name: The Lancet Regional Health - Americas
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.lana.2021.100136
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Brain health: The hidden casualty of a humanitarian crisis
    Journal Name: The Lancet Regional Health - Europe
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.lanepe.2022.100374
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8
    Citation Count: 136
  • Summary Details
    OPEN
    Title: Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104179
    Citation Count: 33
  • Summary Details
    OPEN
    Title: The role of primary and secondary delays in the effective resonance frequency of acoustically interacting microbubbles
    Journal Name: Ultrasonics Sonochemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ultsonch.2022.106033
    Citation Count: 16
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.